Bitget App
Aqlliroq savdo qiling
Kripto sotib olishBozorlarSavdoFyuchersEarnKvadratKo'proq
Narx
Ma'lumot
Haqida
CAH stock price forecast
Yangiliklar
Raqobatchilar
Tokenizatsiya
Kripto
Tez-tez beriladigan savollar
Cardinal Health, Inc. aksiyasi logotipi

Cardinal Health, Inc.

CAH·NYSE

Oxirgi yangilanish: 2026-02-13 18:44 EST Aksiya narxlari haqidagi ma'lumotlar TradingView'dan olingan va real vaqt rejimidagi bozor narxlarini aks ettiradi.

Insaytlar
Kalkulyator
Yangiliklar

CAH aksiya narxining o'zgarishi

Oxirgi savdo kunida, CAH aksiya 215.06 USD narxda yopildi, kun uchun narx o'zgarishi -4.10%.
Aksiya fyucherslari savdosi

Bitget haqida

Dunyodagi birinchi universal birja (UEX) bo'lib, u foydalanuvchilarga nafaqat kriptovalyutalar, balki aksiyalar, ETF, valyutalar, oltin va real aktivlar (RWA) bilan ham savdo qilish imkonini beradi.
Batafsil

CAH asosiy ma'lumotlari

Oldingi yopilish215.06 USD
Bozor qiymati50.61B USD
Hajm3.17M
P/E nisbati30.95
Dividend daromadi (TTM)0.95%
Dividend miqdori0.51 USD
So'nggi dividend to'lash sanasiJan 02, 2026
Oxirgi to'lov sanasiJan 15, 2026
Suyultirilgan EPS (TTM)6.95 USD
Sof daromad (FY)1.56B USD
Daromad (FY)222.57B USD
Keyingi hisobot sanasiApr 30, 2026
EPS taxmini2.760 USD
Taxminiy daromad62.11B USD USD
Savdodagi aksiyalar234.72M
Beta (1Y)0.35
Tokenized stocks

Tokenlashtirilgan aksiyalar haqida eshitganmisiz?

Aksiyalarda savdo qilishning yangi usuli – istalgan vaqtda, istalgan joyda, 24/7.

Batafsil

Cardinal Health, Inc. umumiy ko'rinish

Cardinal Health, Inc. — bu sog‘liqni saqlash xizmatlari va mahsulotlari kompaniyasi bo‘lib, kasalxonalar, sog‘liqni saqlash tizimlari, dorixonalar, ambulator jarrohlik markazlari, klinik laboratoriyalar va shifokor kabinetlari uchun moslashtirilgan yechimlar taqdim etadi. Shuningdek, u tibbiy mahsulotlar va farmatsevtikalarni hamda ta’minot zanjiri samaradorligini oshiruvchi tejamkor yechimlarni taqdim etadi. Kompaniya Farmatsevtika va Tibbiyot segmentlari orqali faoliyat yuritadi. Farmatsevtika segmenti brendli va generik farmatsevtikalar, maxsus farmatsevtikalar hamda retseptsiz sog‘liqni saqlash va iste’mol mahsulotlarini tarqatadi. Tibbiyot segmenti Cardinal Health brendi ostidagi tibbiy, jarrohlik va laboratoriya mahsulotlarini ishlab chiqaradi, yetkazib beradi va tarqatadi. Kompaniya 1979-yilda Robert D. Walter tomonidan tashkil etilgan va bosh ofisi Dublin, OHda joylashgan.
Sektor
Taqsimot xizmatlari
Sanoat
Tibbiy mahsulotlar tarqatuvchilari
CEO
Jason M. Hollar
Bosh shtab
Dublin
Veb-sayt
cardinalhealth.com
Tashkil etilgan
1979
Xodimlar (FY)
57.7K
O'zgarish (1 yil)
+8.8K +18.00%
Daromad / Xodim (1Y)
3.86M USD
Sof daromad / Xodim (1Y)
27.05K USD

CAH impulsi

Daily updates on CAH stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• CAH aksiyalarining narxi 24 soat ichida -4.10% ga o‘zgarib, 224.25 USD dan 215.06 USD ga tushdi.
• Kecha aksiyalar narxining pasayishi asosan logistika va dori tarqatish sektorlaridagi keng ko‘lamli sotuvlar bilan bog‘liq bo‘lib, bu AI logistika dasturiy ta’minot kompaniyalaridan kelgan salbiy yangiliklar sababli yuzaga kelgan, kompaniya har chorakda $0.5107 dividend e’lon qilganiga qaramay.
• Texnik nuqtai nazardan, aksiyalar "uzoq muddatli o‘sish trendida qisqa muddatli orqaga chekinish" ko‘rsatmoqda. U 200 kunlik harakatlanuvchi o‘rtacha ($181.75) darajasidan yuqorida qolmoqda, biroq qisqa muddatli indikatorlar, masalan, 5 kunlik va 10 kunlik SMA, sotish signallariga aylangan va RSI (14) 32 ga yaqinlashib, aksiyalar haddan tashqari sotilgan hududga yaqinlashayotganini ko‘rsatmoqda.
• Cardinal Health (CAH) 12-fevral kuni har bir aksiyaga $0.5107 miqdorida choraklik dividend e’lon qildi, bu kompaniyaning dividendlarni ketma-ket 29 yil davomida oshirganini bildiradi.
• 5-fevral kuni kompaniya Q2 2026 moliyaviy natijalarini e’lon qilib, moslashtirilgan EPS 36% ga oshib $2.63 ga yetganini va 2026 yil uchun butun yil foyda prognozini ko‘tarib chiqdi.
• Institutsional faoliyat yuqori darajada qolmoqda, chunki American Century U.S. Quality Growth ETF yaqinda CAHdagi ulushini 220% dan ortiq oshirdi.
• AQSh Energiya va Savdo Qo‘mitasi 2026-yil 11-fevralda dori-darmon ta’minot zanjiri va PBM islohotlari orqali sog‘liqni saqlash xarajatlarini kamaytirish masalalarini ko‘rib chiqish uchun tinglov o‘tkazdi.
• Sog‘liqni saqlash sektoridagi vertikal integratsiya yana ikki partiyali diqqat markazida, qonunchilar sug‘urta kompaniyalari, dorixonalar va provayderlarning birlashuvi raqobatni cheklaganmi, degan savolni ko‘tarishmoqda.
Ko'proq ko'rish
taxm. 7 soat oldin
• CAH aksiyalarining narxi 24 soat ichida +1.81% o‘sdi. 220.27 USD dan 224.25 USD ga (11-fevral). Bu tiklanish investorlar TD Cowen va Argus kabi yirik banklarning narx maqsadlarini oshirishi, CAHning Q2 daromadlari kutilganidan yuqori chiqishi va butun yil uchun prognoz ko‘tarilishi fonida kichik pasayishdan so‘ng yuz berdi.
• Texnik nuqtai nazardan, aksiyalar kuchli "bullish continuation" bosqichida. CAH 50 kunlik ($207.59) va 200 kunlik ($181.21) o‘rtacha narxlardan ancha yuqorida savdo qilmoqda, bu uzoq muddatli kuchli o‘sish trendini tasdiqlaydi. RSI (taxminan 64) ijobiy impulsni ko‘rsatadi, biroq Stochastics kabi ba’zi osilatorlar aksiyaning haddan tashqari sotib olingan hududga yaqinlashayotganini bildiradi, bu esa qisqa muddatli konsolidatsiyani $230.81 tarixiy eng yuqori narx yaqinida ko‘rsatishi mumkin.
• TD Cowen va Argus 11-fevralda CAH uchun narx maqsadlarini mos ravishda $251 va $248 ga oshirdi, kompaniyaning 36% EPS o‘sishi va Farmatsevtika hamda Maxsus segmentlardagi kuchli natijalarini asos qilib ko‘rsatdi.
• Cardinal Health 2026 moliyaviy yil uchun non-GAAP EPS prognozini $10.15–$10.35 ga ko‘tarib, Q2 daromadlari kutilganidan ancha yuqori bo‘lib, daromad $65.6 milliardga yetganidan so‘ng yangilandi (oldingi prognoz $9.65–$9.85 edi).
• Kompaniya qo‘shimcha $375 million tezlashtirilgan aksiyalarni qayta sotib olish dasturini yakunladi, bu yil boshidan jami $750 millionni tashkil etdi, bu esa pul oqimi va baholashga kuchli ishonchni bildiradi.
• AQSh Energiya va Savdo Qo‘mitasi 11-fevralda "Retsept bo‘yicha dori-darmon ta’minot zanjirini ko‘rib chiqish" mavzusida eshituv o‘tkazdi, PBMlar va distributorlarga tibbiy xarajatlarni kamaytirish uchun e’tibor qaratildi, bu distributorlarga kelajakdagi tartibga solish muhitiga ta’sir qilishi mumkin.
• Sog‘liqni saqlash sohasidagi yirik hamkor McKesson (MCK) Yevropa operatsiyalaridan chiqishni yakunlab, Shimoliy Amerika onkologiyasi va maxsus o‘sishga e’tibor qaratdi, bu strategik o‘zgarish CAHning yuqori marjali maxsus dori vositalariga so‘nggi e’tiboriga mos keladi.
Ko'proq ko'rish
taxm. 1 kun oldin

CAH stock price forecast

According to technical indicators for CAH stock, the price is likely to fluctuate within the range of 258.04–298.45 USD over the next week. Market analysts predict that the price of CAH stock will likely fluctuate within the range of 181.96–333.46 USD over the next months.

Based on 1-year price forecasts from 79 analysts, the highest estimate is 640.04 USD, while the lowest estimate is 202.05 USD.

For more information, please see the CAH stock price forecast Stock Price Forecast page.

Bitget hisobi bilan siz bir vaqtning o'zida aksiyalar va kriptovalyutalar bilan savdo qilishingiz mumkin.

Hoziroq qo'shilish!

Tez-tez beriladigan savollar

Cardinal Health, Inc. aksiya narxi qancha?

CAH joriy narxi 215.06 USD – uning narxi oxirgi 24 soat ichida -4.10% ga o'zgargan. Ushbu sahifaning yuqori qismidagi narxlar grafigida Cardinal Health, Inc. aksiyasi narxi ko'rsatkichlarini batafsilroq kuzatishingiz mumkin.

Cardinal Health, Inc. aksiya tikeri nima?

Birjaga ko'ra, aksiya tikeri farq qilishi mumkin. Masalan, NYSE, Cardinal Health, Inc. – CAH tikeri bilan savdo qilinadi.

CAH aksiya prognozi qancha?

Biz Cardinal Health, Inc.ning kelajakdagi narxi borasida tahlilchilar fikrlarini to'pladik. Ularning prognozlariga ko'ra, CAHning maksimal bahosi 2150.60 USD va minimal bahosi 430.12 USD.

Cardinal Health, Inc. bozor qiymati qancha?

Cardinal Health, Inc. bozor kapitalizatsiyasi – 50.61B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Xavf haqida ogohlantirish:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official Fee overview or Announcement Center page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.